JNCCN released an article in the February issue with insights on:
Prostate cancer screening:
- Review of genes/risks: BRCA1/2, HOXB13, ATM, CHEK2, MSH2, PALB2, and TP53
- Prostate MRI recommended screening is done in experienced high-volume centers after an in-depth discussion
Pancreatic cancer screening:
- Screening without need for family history: CDKN2A, STK11, ATM, BRCA2
- Family history needed: BRCA1, MSH2, MLH1, MSH6, EPCAM, PALB2, TP53
Testing for non-epithelial ovarian cancer:
- SCCOHT: test for DICER1
- SCTAT: test for STK11 (Peutz-Jeghers)
- Given rarity, consultation with expert may be considered
Cheng, et al. J Natl Compr Cancer Netw. 2026:24(2):2-10. PMID: 41671423.Article available at: https://jnccn.org/view/journals/jnccn/24/2/article-p2.xml. Social media post available at: https://www.facebook.com/share/p/1Rk6tvn2AB/